These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9495818)

  • 1. Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies.
    Howlett AC; Song C; Berglund BA; Wilken GH; Pigg JJ
    Mol Pharmacol; 1998 Mar; 53(3):504-10. PubMed ID: 9495818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains.
    Mukhopadhyay S; Howlett AC
    Eur J Biochem; 2001 Feb; 268(3):499-505. PubMed ID: 11168387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Gi by the CB1 cannabinoid receptor C-terminal juxtamembrane region: structural requirements determined by peptide analysis.
    Mukhopadhyay S; Cowsik SM; Lynn AM; Welsh WJ; Howlett AC
    Biochemistry; 1999 Mar; 38(11):3447-55. PubMed ID: 10079092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain.
    Mukhopadhyay S; McIntosh HH; Houston DB; Howlett AC
    Mol Pharmacol; 2000 Jan; 57(1):162-70. PubMed ID: 10617691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs.
    Abadji V; Lucas-Lenard JM; Chin C; Kendall DA
    J Neurochem; 1999 May; 72(5):2032-8. PubMed ID: 10217281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CB1 cannabinoid receptor in the brain.
    Howlett AC
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):405-16. PubMed ID: 9974174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle.
    Holland M; John Challiss RA; Standen NB; Boyle JP
    Br J Pharmacol; 1999 Oct; 128(3):597-604. PubMed ID: 10516638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling.
    Nie J; Lewis DL
    Neuroscience; 2001; 107(1):161-7. PubMed ID: 11744255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2.
    McKenzie FR; Milligan G
    Biochem J; 1990 Apr; 267(2):391-8. PubMed ID: 2159280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling.
    Tao Q; Abood ME
    J Pharmacol Exp Ther; 1998 May; 285(2):651-8. PubMed ID: 9580609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
    Bouaboula M; Poinot-Chazel C; Bourrié B; Canat X; Calandra B; Rinaldi-Carmona M; Le Fur G; Casellas P
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):637-41. PubMed ID: 8526880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.
    Shim JY; Khurana L; Kendall DA
    Proteins; 2016 Apr; 84(4):532-43. PubMed ID: 26994549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells.
    Tallent M; Reisine T
    Mol Pharmacol; 1992 Mar; 41(3):452-5. PubMed ID: 1347639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum.
    Selley DE; Cassidy MP; Martin BR; Sim-Selley LJ
    Mol Pharmacol; 2004 Nov; 66(5):1275-84. PubMed ID: 15286206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles of the tyrosine within the NP(X)(n)Y motif and the cysteines in the C-terminal juxtamembrane region of the CB2 cannabinoid receptor.
    Feng W; Song ZH
    FEBS Lett; 2001 Jul; 501(2-3):166-70. PubMed ID: 11470278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail.
    Andersson H; D'Antona AM; Kendall DA; Von Heijne G; Chin CN
    Mol Pharmacol; 2003 Sep; 64(3):570-7. PubMed ID: 12920192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.